Paloma Partners’s AdaptHealth AHCO Stock Holding History

Paloma Partners’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,958	Closed	-$261K	–	2000
2020 Q4	$261K	Buy	+6,958	New	+$215K	0.01%	1235

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Paloma Partners's AHCO Position: Q1 2021 in Review

Paloma Partners sold out of AdaptHealth (AHCO) in Q1 2021, closing a stake of 6,958 shares — an estimated $261K sold.

Paloma Partners first reported a position in AHCO in Q4 2020 and held it in 1 quarter. The position peaked at $261K in Q4 2020. 145 funds tracked by Wall St. Rank hold AHCO as of Q1 2021.

Paloma Partners reported no remaining AdaptHealth position as of Q1 2021 after selling out during the quarter.
Paloma Partners sold 6,958 AdaptHealth shares in Q1 2021, an estimated $261K.
Paloma Partners first reported a position in AdaptHealth in Q4 2020 and held it in 1 quarter.
Paloma Partners's AdaptHealth position peaked at $261K in Q4 2020.
145 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2021.

Based on Paloma Partners's 13F filing for Q1 2021, filed 17 May 2021.